Rare diseases
Investigational molecules
Locations
Back to Slovakia231 clinical trials in Kosice, Slovakia across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)SlovakiaLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
SlovakiaBI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases
SlovakiaA study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer's disease
SlovakiaA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
SlovakiaA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
SlovakiaStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
SlovakiaA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
SlovakiaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
SlovakiaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
SlovakiaA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
SlovakiaA study testing duvakitug for patients with moderately to severely active ulcerative colitis
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on chronic respiratory conditions, including studies evaluating new treatments for COPD and uncontrolled asthma. Trials are examining novel therapeutic approaches to improve patient outcomes and quality of life.
Research includes evaluation of medications like tezepelumab for COPD and AZD8630 for asthma control.
Comprehensive studies addressing cardiovascular health and metabolic conditions, from heart failure prevention to lipid disorders management.
Current trials are exploring innovative combinations of medications for cardiovascular risk reduction and metabolic control.
Advanced research into inflammatory and autoimmune disorders, including studies on Crohn's disease, ulcerative colitis, and Sjögren's syndrome.
Trials are evaluating novel biological treatments and targeted therapies for various autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
